GOIZ ZAINDU Feasibility Multi Domain Trial to Prevent Dementia.
Conditions: Cognitive Decline; Dementia Risk Factors; Prevention; Multidomain Intervention Interventions: Behavioral: Multidomain intervention (MD-Int) group Sponsors: Fundacion CITA-alzheimer; Biogipuzkoa Health Research Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease
Conditions: Alzheimer Disease Interventions: Device: NirsCure-9000 series; Device: sham NirsCure-9000 series Sponsors: Xuanwu Hospital, Beijing; Danyang Huichuang Medical Equipment Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
ACP-204 in Adults With Alzheimer's Disease Psychosis
Conditions: Alzheimer ' s Disease Psychosis Interventions: Drug: ACP-204; Drug: Placebo Sponsors: ACADIA Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
Conditions: Alzheimer Disease Interventions: Procedure: MR guided low intensity focused ultrasound Sponsors: Kyung Won Chang; Yonsei University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Music-Based Interventions, Aging, Alzheimer's Disease
Conditions: Community Choir Program or Group Music Listening Program Interventions: Behavioral: Choir; Behavioral: Group Music Listening Sponsors: University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate XTR006 in Chinese Volunteers
Conditions: Alzheimer Disease Interventions: Diagnostic Test: XTR006 Sponsors: Sinotau Pharmaceutical Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects
Conditions: Alzheimer Disease Interventions: Drug: XTR006 Sponsors: Sinotau Pharmaceutical Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Impact of a Biophoton Therapy on Patients With Brain Disorders
Conditions: Brain Disorders - Alzheimer ' s Disease, Dementia, Parkinson ' s Disease, Traumatic Brain Injury Interventions: Device: Biophotonizer - a Biophoton Generator Sponsors: First Institute of All Medicines Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging
Conditions: Positron Emission Tomography; Alzheimer Disease; Neurodegenerative Diseases Interventions: Radiation: [18F]CSF-23 Sponsors: Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease
Conditions: Alzheimer ' s Disease Interventions: Drug: [18F]Florbetazine ([18F]92); Drug: [11C]PIB Sponsors: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD)
Conditions: Dementia; Agitation; Depressive Symptoms Interventions: Behavioral: Feasibility study of music-based mobile app Sponsors: Autotune Me LLC; University of Pennsylvania; National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
Phase 2 Spring Trial Of LHP588, Treatment For P. Gingivalis-positive Alzheimer's Disease Proceeds
SAN FRANCISCO, Nov. 16, 2023. Lighthouse Pharmaceuticals, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of Alzheimer ' s and other diseases of aging, today announced clearance by the U.S. Food and Drug... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 16, 2023 Category: Pharmaceuticals Source Type: clinical trials
CONFIDENCE-AI Financial Education for Caregivers (CONFIDENCE-AI)
Conditions: Alzheimer Disease; Dementia; Caregiver Burden; Financial Stress Interventions: Behavioral: CONFIDENCE-AI Sponsors: Case Western Reserve University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Ultrasonic Neuromodulation for Treatment of Cognitive Impairment
Conditions: Alzheimer Disease; Dementia; Cognitive Impairment Interventions: Device: Diadem prototype Sponsors: University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
Conditions: Alzheimer Disease Interventions: Drug: [11C]-CS1P1 Sponsors: Washington University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
